Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin effects on Alzheimer's pathobiology (ESPRIT)
NCT00486044Phase 2Completed
- Sponsor
- University of Wisconsin–Madison
- Start
- Feb 2005
- Primary completion
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of simvastatin in Alzheimer's disease (AD), sponsored by University of Wisconsin–Madison. Started Feb 2005; status: completed.
02
Drugs
simvastatin
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00486044.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00486044.